- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 237/38 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to a carbon atom of a ring other than a six-membered aromatic ring
Patent holdings for IPC class C07C 237/38
Total number of patents in this class: 23
10-year publication summary
|
0
|
3
|
0
|
0
|
2
|
2
|
1
|
4
|
0
|
3
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novartis AG | 10172 |
2 |
| The Regents of the University of California | 20924 |
2 |
| Boehringer Ingelheim International GmbH | 4480 |
2 |
| Takeda Pharmaceutical Company Limited | 2700 |
2 |
| Ishihara Sangyo Kaisha, Ltd. | 660 |
2 |
| Milliken & Company | 1143 |
2 |
| Bristol-myers Squibb Company | 4761 |
1 |
| Tsinghua University | 6259 |
1 |
| National Institute of Advanced Industrial Science and Technology | 3793 |
1 |
| CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. | 235 |
1 |
| JE IL Pharmaceutical Co., Ltd. | 65 |
1 |
| Southern Research Institute | 203 |
1 |
| Sunshine Lake Pharma Co., Ltd. | 631 |
1 |
| Uniwersytet Warszawski | 170 |
1 |
| Sanofi | 4332 |
1 |
| Epiodyne, Inc. | 7 |
1 |
| Escient Pharmaceuticals, Inc. | 29 |
1 |
| Other owners | 0 |